CCL21 and non-small cell lung carcinoma: Our group previously reported on the first-in-man administration of CCL21 and the first trial of transthoracic, intratumoral in situ vaccination with Ad-CCL21-DC in the treatment of locally advanced or metastatic NSCLC.17